{"id":4698,"date":"2024-11-14T13:05:37","date_gmt":"2024-11-14T03:05:37","guid":{"rendered":"\/eu-uk\/?p=4698"},"modified":"2024-11-14T13:05:37","modified_gmt":"2024-11-14T03:05:37","slug":"stockhead-long-shortz-no-nerves-as-company-enters-us-market","status":"publish","type":"post","link":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/","title":{"rendered":"Stockhead Long Shortz | No nerves as company enters US market"},"content":{"rendered":"<div class=\"xdj266r x11i5rnm xat24cr x1mh8g0r x1vvkbs x126k92a\">\n<div dir=\"auto\">This week <span class=\"html-span xdj266r x11i5rnm xat24cr x1mh8g0r xexx8yu x4uap5 x18d9i69 xkhd6sd x1hl2dhg x16tdsg8 x1vvkbs\"><span class=\"xt0psk2\">Orthocell<\/span><\/span> announced the appointment to two new US-based executives as the Company prepares to enter the US market with its nerve repair product, Remplir\u2122.<\/div>\n<\/div>\n<div class=\"x11i5rnm xat24cr x1mh8g0r x1vvkbs xtlvy1s x126k92a\">\n<div dir=\"auto\"><\/div>\n<\/div>\n<div class=\"x11i5rnm xat24cr x1mh8g0r x1vvkbs xtlvy1s x126k92a\">\n<div dir=\"auto\">Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company&#8217;s strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity.<\/div>\n<\/div>\n<div class=\"x11i5rnm xat24cr x1mh8g0r x1vvkbs xtlvy1s x126k92a\">\n<div dir=\"auto\"><\/div>\n<div dir=\"auto\">Here&#8217;s an excerpt:<\/div>\n<div dir=\"auto\"><\/div>\n<\/div>\n<div class=\"x11i5rnm xat24cr x1mh8g0r x1vvkbs xtlvy1s x126k92a\">\n<div dir=\"auto\"><em>&#8220;The difference between Orthocell is you&#8217;ve got a product that&#8217;s already been used in human bodies. There&#8217;s over $35 million of cash on the balance sheet, and it&#8217;s already in revenue with existing regulatory approval. It has crossed that threshold between this amazing concept and something that&#8217;s actually generating revenue&#8230; it&#8217;s a very low risk biotech compared to the majority of other smaller cap stocks. People are realising this is right on the threshold of coming into profit and significant growth.&#8221;<\/em><\/div>\n<\/div>\n<div dir=\"auto\"><\/div>\n<div dir=\"auto\"><a href=\"https:\/\/bit.ly\/OCC-Stockhead-JVW\">Click to view the interview.\u00a0<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company&#8217;s strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity.<\/p>\n","protected":false},"author":2,"featured_media":2613,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4698","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-video"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company&#039;s strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Orthocell\"\/>\n\t<link rel=\"canonical\" href=\"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Orthocell EU\/UK -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Stockhead Long Shortz | No nerves as company enters US market - Orthocell EU\/UK\" \/>\n\t\t<meta property=\"og:description\" content=\"Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company&#039;s strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity.\" \/>\n\t\t<meta property=\"og:url\" content=\"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-11-14T03:05:37+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-11-14T03:05:37+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Stockhead Long Shortz | No nerves as company enters US market - Orthocell EU\/UK\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company&#039;s strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#blogposting\",\"name\":\"Stockhead Long Shortz | No nerves as company enters US market - Orthocell EU\\\/UK\",\"headline\":\"Stockhead Long Shortz | No nerves as company enters US market\",\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2018\\\/06\\\/OCC-WEBSITE-IMAGES-5.png\",\"width\":2000,\"height\":1428},\"datePublished\":\"2024-11-14T13:05:37+10:00\",\"dateModified\":\"2024-11-14T13:05:37+10:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#webpage\"},\"articleSection\":\"Video\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"name\":\"Video\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"position\":2,\"name\":\"Video\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#listItem\",\"name\":\"Stockhead Long Shortz | No nerves as company enters US market\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#listItem\",\"position\":3,\"name\":\"Stockhead Long Shortz | No nerves as company enters US market\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"name\":\"Video\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\",\"name\":\"Orthocell EU\\\/UK\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/\",\"name\":\"Orthocell\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Orthocell\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#webpage\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/\",\"name\":\"Stockhead Long Shortz | No nerves as company enters US market - Orthocell EU\\\/UK\",\"description\":\"Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company's strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity.\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2018\\\/06\\\/OCC-WEBSITE-IMAGES-5.png\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#mainImage\",\"width\":2000,\"height\":1428},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/11\\\/14\\\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\\\/#mainImage\"},\"datePublished\":\"2024-11-14T13:05:37+10:00\",\"dateModified\":\"2024-11-14T13:05:37+10:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\",\"name\":\"Orthocell EU\\\/UK\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Stockhead Long Shortz | No nerves as company enters US market - Orthocell EU\/UK","description":"Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company's strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity.","canonical_url":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#blogposting","name":"Stockhead Long Shortz | No nerves as company enters US market - Orthocell EU\/UK","headline":"Stockhead Long Shortz | No nerves as company enters US market","author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"publisher":{"@id":"\/eu-uk\/#organization"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2018\/06\/OCC-WEBSITE-IMAGES-5.png","width":2000,"height":1428},"datePublished":"2024-11-14T13:05:37+10:00","dateModified":"2024-11-14T13:05:37+10:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#webpage"},"isPartOf":{"@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#webpage"},"articleSection":"Video"},{"@type":"BreadcrumbList","@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","position":1,"name":"Home","item":"https:\/\/orthocell.com\/eu-uk","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","name":"Video"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","position":2,"name":"Video","item":"\/eu-uk\/blog\/category\/video\/","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#listItem","name":"Stockhead Long Shortz | No nerves as company enters US market"},"previousItem":{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","name":"Home"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#listItem","position":3,"name":"Stockhead Long Shortz | No nerves as company enters US market","previousItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","name":"Video"}}]},{"@type":"Organization","@id":"\/eu-uk\/#organization","name":"Orthocell EU\/UK","url":"\/eu-uk\/"},{"@type":"Person","@id":"\/eu-uk\/blog\/author\/hcartres\/#author","url":"\/eu-uk\/blog\/author\/hcartres\/","name":"Orthocell","image":{"@type":"ImageObject","@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g","width":96,"height":96,"caption":"Orthocell"}},{"@type":"WebPage","@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#webpage","url":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/","name":"Stockhead Long Shortz | No nerves as company enters US market - Orthocell EU\/UK","description":"Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company's strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity.","inLanguage":"en-GB","isPartOf":{"@id":"\/eu-uk\/#website"},"breadcrumb":{"@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#breadcrumblist"},"author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"creator":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2018\/06\/OCC-WEBSITE-IMAGES-5.png","@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#mainImage","width":2000,"height":1428},"primaryImageOfPage":{"@id":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/#mainImage"},"datePublished":"2024-11-14T13:05:37+10:00","dateModified":"2024-11-14T13:05:37+10:00"},{"@type":"WebSite","@id":"\/eu-uk\/#website","url":"\/eu-uk\/","name":"Orthocell EU\/UK","inLanguage":"en-GB","publisher":{"@id":"\/eu-uk\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Orthocell EU\/UK -","og:type":"article","og:title":"Stockhead Long Shortz | No nerves as company enters US market - Orthocell EU\/UK","og:description":"Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company's strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity.","og:url":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/","article:published_time":"2024-11-14T03:05:37+00:00","article:modified_time":"2024-11-14T03:05:37+00:00","twitter:card":"summary_large_image","twitter:title":"Stockhead Long Shortz | No nerves as company enters US market - Orthocell EU\/UK","twitter:description":"Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company's strategic positioning ahead of its US market entry, sharing insights on why Remplir represents a compelling investment opportunity."},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/orthocell.com\/eu-uk\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"\/eu-uk\/blog\/category\/video\/\" title=\"Video\">Video<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tStockhead Long Shortz | No nerves as company enters US market\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/orthocell.com\/eu-uk"},{"label":"Video","link":"\/eu-uk\/blog\/category\/video\/"},{"label":"Stockhead Long Shortz | No nerves as company enters US market","link":"\/eu-uk\/blog\/2024\/11\/14\/stockhead-long-shortz-no-nerves-as-company-enters-us-market\/"}],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4698"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4698\/revisions"}],"predecessor-version":[{"id":4699,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4698\/revisions\/4699"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/2613"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4698"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}